Benzz 180 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Benzz 180 mg Injection

Benzz 180 mg Injection

Benzz 180 mg Injection contains bendamustine 180 mg and is an injectable anticancer medicine. It is used for certain blood cancers, including chronic lymphocytic leukemia and non-Hodgkin lymphoma. The injection is administered by a healthcare professional through intravenous infusion under specialist supervision.

BUY NOW

Category

Bendamustine is an alkylating chemotherapy medicine that damages the DNA of cancer cells and interferes with their growth and multiplication. It may be used alone or with other medicines depending on the cancer type and prescribed treatment protocol. Regular monitoring of blood counts and organ function is important because treatment can cause anemia, low white blood cell counts, infections, fatigue, and nausea. The dosage and treatment schedule are individualized by the treating oncologist according to the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Bendamustine
Strength 180 mg
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Benzz 180mg Injection, Benzz 180 mg Injection, Bendamustine 180mg Injection, Bendamustine 180 mg Injection, Bendamustine Hydrochloride 180mg Injection, Bendamustine Oncology Injection